OPTIMI HEALTH CORP. Market Cap ($683.89K)
Market Cap & Net Worth: OPTIMI HEALTH CORP. (8BN)
OPTIMI HEALTH CORP. market cap. OPTIMI HEALTH CORP. (F:8BN) has a market capitalization of $683.89K (€584.97K) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #30899 globally and #2706 in its home market, demonstrating a 1616.98% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying OPTIMI HEALTH CORP.'s stock price €3.64 by its total outstanding shares 3225897 (3.23 Million). Also see 8BN cash flow metrics for how efficiently the company converts equity into cash flow.
OPTIMI HEALTH CORP. Market Cap History (2021–2026)
OPTIMI HEALTH CORP. market cap history from 2021 to 2026. Data shows growth from $1.22 Million to $13.73 Million (46.69% CAGR). Check latest OPTIMI HEALTH CORP. stock price today for real-time trading data and today's change.
OPTIMI HEALTH CORP. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how OPTIMI HEALTH CORP.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore OPTIMI HEALTH CORP. (8BN) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.75x
OPTIMI HEALTH CORP.'s market cap is 1.75 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $610.21K | $80.72K | -$7.35 Million | 7.56x | N/A |
| 2023 | $429.94K | $181.09K | -$5.19 Million | 2.37x | N/A |
| 2024 | $543.08K | $389.85K | -$6.04 Million | 1.39x | N/A |
| 2025 | $746.74K | $426.30K | -$3.71 Million | 1.75x | N/A |
Competitor Companies of 8BN by Market Capitalization
Companies near OPTIMI HEALTH CORP. in the global market cap rankings as of November 3, 2026. Also see 8BN asset base for a full breakdown of the balance sheet.
Key companies related to OPTIMI HEALTH CORP. by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #516 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #591 globally with a market cap of $45.45 Billion USD ( CN¥310.59 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #516 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.55 |
| #591 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.45 Billion | CN¥48.69 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of OPTIMI HEALTH CORP. (2021–2026)
Market capitalization of OPTIMI HEALTH CORP. from 2021 to today. Between 2021 and today, OPTIMI HEALTH CORP.'s market cap moved from $1.22 Million to $ 13.73 Million, with a yearly change of 46.69%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €13.73 Million | +1738.38% |
| 2025 | €746.74K | +37.50% |
| 2024 | €543.08K | +26.32% |
| 2023 | €429.94K | -29.54% |
| 2022 | €610.21K | -49.91% |
| 2021 | €1.22 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of OPTIMI HEALTH CORP. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $683.89K USD |
| MoneyControl | $683.89K USD |
| MarketWatch | $683.89K USD |
| marketcap.company | $683.89K USD |
| Reuters | $683.89K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About OPTIMI HEALTH CORP.
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and… Read more